Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.
Hose D, Ray S, Rößler S, Thormann U, Schnettler R, de Veirman K, El Khassawna T, Heiss C, Hild A, Zahner D, Alagboso F, Henss A, Beck S, Emde-Rajaratnam M, Burhenne J, Bamberger J, Menu E, de Bruyne E, Gelinsky M, Kampschulte M, Rohnke M, Wenisch S, Vanderkerken K, Hanke T, Seckinger A, Alt V. Hose D, et al. Among authors: de bruyne e. J Hematol Oncol. 2024 Dec 18;17(1):128. doi: 10.1186/s13045-024-01636-4. J Hematol Oncol. 2024. PMID: 39695697 Free PMC article.
Metabolic cross-talk within the bone marrow milieu: focus on multiple myeloma.
Oudaert I, Van der Vreken A, Maes A, De Bruyne E, De Veirman K, Vanderkerken K, Menu E. Oudaert I, et al. Among authors: de bruyne e, de veirman k. Exp Hematol Oncol. 2022 Sep 1;11(1):49. doi: 10.1186/s40164-022-00303-z. Exp Hematol Oncol. 2022. PMID: 36050788 Free PMC article. Review.
The effects of forodesine in murine and human multiple myeloma cells.
Bieghs L, Caers J, De Bruyne E, Van Valckenborgh E, Higginbotham F, Vanderkerken K, Menu E. Bieghs L, et al. Among authors: de bruyne e. Adv Hematol. 2010;2010:131895. doi: 10.1155/2010/131895. Epub 2010 Oct 19. Adv Hematol. 2010. PMID: 20981156 Free PMC article.
In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma.
Maes K, De Smedt E, Kassambara A, Hose D, Seckinger A, Van Valckenborgh E, Menu E, Klein B, Vanderkerken K, Moreaux J, De Bruyne E. Maes K, et al. Among authors: de smedt e, de bruyne e. Oncotarget. 2015 Feb 20;6(5):3319-34. doi: 10.18632/oncotarget.3207. Oncotarget. 2015. PMID: 25669970 Free PMC article.
Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells.
De Veirman K, Van Ginderachter JA, Lub S, De Beule N, Thielemans K, Bautmans I, Oyajobi BO, De Bruyne E, Menu E, Lemaire M, Van Riet I, Vanderkerken K, Van Valckenborgh E. De Veirman K, et al. Among authors: de bruyne e, de beule n. Oncotarget. 2015 Apr 30;6(12):10532-47. doi: 10.18632/oncotarget.3300. Oncotarget. 2015. PMID: 25871384 Free PMC article.
103 results